Multiple Breath Washout (MBW) Using Sulfur Hexafluoride Reference Values and Influence of Anthropometric Parameters
Launched by UNIVERSITÄTSMEDIZIN MANNHEIM · Sep 19, 2019
Trial Information
Current as of September 26, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • non-smoker
- • no history of pulmonary disease
- • absence of dyspnoea, cough, thoracic pain
- • no self-reported smoking history
- • normal lung function testing
- • normal shape of flow-volume curve
- • normal shape of flow-pressure curve
- • FEV1/FVC \>70% (forced expiratory volume in 1 second / forced vital capacity)
- • TLC \> 80% of predicted (total lung capacity)
- • TLCO/VA \> 80% of predicted (transfer factor corrected for ventilated alveolar volume)
- • R5 \< 150% of predicted (resistance at 5Hz, impulse oscillometry)
- • smoker
- • - as above, but with self-reported smoking history \>10 pack years
- Exclusion Criteria:
- • unwilling or unable to give informed consent
- • history of any respiratory disease
About Universitätsmedizin Mannheim
Universitätsmedizin Mannheim is a leading academic medical center affiliated with Heidelberg University, dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on translational medicine, the institution integrates cutting-edge scientific discovery with patient care, fostering collaboration among multidisciplinary teams. Its state-of-the-art facilities and commitment to ethical research practices position Universitätsmedizin Mannheim as a pivotal contributor to the development of new therapies and medical technologies, ultimately enhancing patient outcomes and contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Frederik Trinkmann, MD
Principal Investigator
University Medical Center Mannheim
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials